11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

31 trials found

diseases per page:

Showing 1 to 10 of 31 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2016-001384-37-NL (EUCTR)	13/04/2021	14/12/2020	An Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodyn ...	An Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodyn ...	Refractory Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417 ...	Trade Name: Soliris Product Name: Soliris Product Code: Soliris INN or Proposed INN: ECULIZUMAB	Alexion Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 3	United States;Canada;Germany;Netherlands;Japan
2	EUCTR2016-001384-37-DE (EUCTR)	07/10/2020	17/12/2018	An Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodyn ...	An Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodyn ...	Refractory Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417 ...	Trade Name: Soliris Product Name: Soliris Product Code: Soliris INN or Proposed INN: ECULIZUMAB	Alexion Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	17	Phase 3	United States;Canada;Netherlands;Germany;Japan
3	NCT03759366 (ClinicalTrials.gov)	December 21, 2018	26/11/2018	A Phase 3 Open-Label Study of Eculizumabin Pediatric Participants With Refractory Generalized Myasth ...	An Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodyn ...	Myasthenia Gravis;Myasthenia Gravis, Juvenile Form;Myasthenia Gravis, Generalized	Drug: Eculizumab	Alexion Pharmaceuticals	NULL	Active, not recruiting	6 Years	17 Years	All	11	Phase 3	United States;Japan;Netherlands
4	EUCTR2013-002191-41-CZ (EUCTR)	08/10/2015	31/08/2015	EXTENSION STUDY OF ECU-MG-301 TO EVALUATE ECULIZUMABIN REFRACTORY GENERALIZED MYASTHENIA GRAVIS (GMG ...	A PHASE III, OPEN-LABEL, EXTENSION TRIAL OF ECU-MG-301 TO EVALUATE THE SAFETY AND EFFICACY OF ECULIZ ...	Generalized Myasthenia Gravis MedDRA version: 19.1;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: SOLIRIS Product Name: Soliris INN or Proposed INN: ECULIZUMAB	Alexion Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	92	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Greece;Spain;Ireland;Russian Federation;Israel;Switzerland;Italy;France;Australia;Denm ...
5	EUCTR2013-002191-41-FI (EUCTR)	01/10/2015	25/09/2015	EXTENSION STUDY OF ECU-MG-301 TO EVALUATE ECULIZUMABIN REFRACTORY GENERALIZED MYASTHENIA GRAVIS (GMG ...	A PHASE III, OPEN-LABEL, EXTENSION TRIAL OF ECU-MG-301 TO EVALUATE THE SAFETY AND EFFICACY OF ECULIZ ...	Generalized Myasthenia Gravis MedDRA version: 20.0;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: SOLIRIS Product Name: Soliris INN or Proposed INN: ECULIZUMAB	Alexion Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	92	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	Greece;Spain;Ireland;Russian Federation;Israel;Switzerland;Italy;France;Australia;Denmark;Netherland ...
6	EUCTR2013-002191-41-NL (EUCTR)	31/08/2015	28/01/2015	EXTENSION STUDY OF ECU-MG-301 TO EVALUATE ECULIZUMABIN REFRACTORY GENERALIZED MYASTHENIA GRAVIS (GMG ...	A PHASE III, OPEN-LABEL, EXTENSION TRIAL OF ECU-MG-301 TO EVALUATE THE SAFETY AND EFFICACY OF ECULIZ ...	Generalized Myasthenia Gravis MedDRA version: 20.0;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: SOLIRIS INN or Proposed INN: ECULIZUMAB	Alexion Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	92	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Greece;Spain;Ireland;Switzerland;Italy;France;Australia;Denmark;Netherlands;Korea, Rep ...
7	EUCTR2013-002191-41-DK (EUCTR)	03/06/2015	16/04/2015	EXTENSION STUDY OF ECU-MG-301 TO EVALUATE ECULIZUMABIN REFRACTORY GENERALIZED MYASTHENIA GRAVIS (GMG ...	A PHASE III, OPEN-LABEL, EXTENSION TRIAL OF ECU-MG-301 TO EVALUATE THE SAFETY AND EFFICACY OF ECULIZ ...	Generalized Myasthenia Gravis MedDRA version: 20.0;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: SOLIRIS Product Name: Soliris INN or Proposed INN: ECULIZUMAB	Alexion Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	92	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Greece;Spain;Ireland;Russian Federation;Israel;Switzerland;Italy;France;Australia;Denm ...
8	EUCTR2013-002191-41-ES (EUCTR)	29/04/2015	26/01/2015	EXTENSION STUDY OF ECU-MG-301 TO EVALUATE ECULIZUMABIN REFRACTORY GENERALIZED MYASTHENIA GRAVIS (GMG ...	A PHASE III, OPEN-LABEL, EXTENSION TRIAL OF ECU-MG-301 TO EVALUATE THE SAFETY AND EFFICACY OF ECULIZ ...	Generalized Myasthenia Gravis MedDRA version: 18.0;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: SOLIRIS INN or Proposed INN: ECULIZUMAB	Alexion Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	92	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Greece;Finland;Spain;Ireland;Turkey;Austria;Italy;Switzerland;United Kingdom;France;Cz ...
9	EUCTR2013-003589-15-CZ (EUCTR)	22/04/2015	26/02/2015	STUDY OF ECULIZUMAB IN REFRACTORY GENERALIZED MYASTHENIA GRAVIS (GMG)SUBJECTS	A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED,MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY ...	Generalized Myasthenia Gravis MedDRA version: 19.0;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: SOLIRIS Product Name: Soliris INN or Proposed INN: ECULIZUMAB	Alexion Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	92	Phase 3	United States;Greece;Spain;Ireland;Russian Federation;Israel;Switzerland;Italy;France;Australia;Denm ...
10	EUCTR2013-003589-15-HU (EUCTR)	31/03/2015	20/01/2015	STUDY OF ECULIZUMAB IN REFRACTORY GENERALIZED MYASTHENIA GRAVIS (GMG)SUBJECTS	A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED,MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY ...	Generalized Myasthenia Gravis MedDRA version: 17.1;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: SOLIRIS Product Name: Soliris INN or Proposed INN: ECULIZUMAB	Alexion Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	92	Phase 3	United States;Greece;Spain;Ireland;Russian Federation;Israel;Switzerland;Italy;France;Australia;Denm ...

First Previous1 2 3 4Next Last